(Q36788365)

16 August 2017

1 reference

title

Montelukast in the treatment of allergic rhinitis: an evidence-based review (English)

1 reference

16 August 2017

1 reference

Anjuli Nayak

1

1 reference

PubMed ID

17428106

16 August 2017

Ronald B Langdon

series ordinal

2

1 reference

16 August 2017

1 January 2007

1 reference

16 August 2017

1 reference

16 August 2017

67

1 reference

16 August 2017

6

1 reference

16 August 2017

887-901

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200767060-00005

16 August 2017

0 references

cites work

Cysteinyl leukotrienes and their receptors: cellular distribution and function in immune and inflammatory responses

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003495-200767060-00005

Cysteinyl leukotrienes regulate dendritic cell functions in a murine model of asthma

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003495-200767060-00005

Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire.

21 January 2018

1 reference

12 December 2020

Fluticasone propionate aqueous nasal spray provided significantly greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukast

1 reference

12 December 2020

Evidence-based strategies for treatment of allergic rhinitis

1 reference

12 December 2020

Inhaled corticosteroids and Churg-Strauss syndrome: a report of five cases

1 reference

12 December 2020

Montelukast plus cetirizine in the prophylactic treatment of seasonal allergic rhinitis: influence on clinical symptoms and nasal allergic inflammation

1 reference

12 December 2020

Combined mediator blockade or topical steroid for treating the unified allergic airway

1 reference

12 December 2020

Pharmacotherapy for allergic rhinitis: a critical review of leukotriene receptor antagonists compared with other treatments

1 reference

12 December 2020

Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis

1 reference

12 December 2020

Burden of concomitant allergic rhinitis in adults with asthma

1 reference

12 December 2020

Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis

1 reference

12 December 2020

Churg-Strauss syndrome

1 reference

12 December 2020

The role of antileukotriene therapy in seasonal allergic rhinitis: a systematic review of randomized trials

1 reference

12 December 2020

The diagnosis of asthma using a self-questionnaire in those suffering from allergic rhinitis: a pharmaco-epidemiological survey in everyday practice in France

1 reference

12 December 2020

Segmental bronchial provocation induces nasal inflammation in allergic rhinitis patients

1 reference

12 December 2020

Adherence to Prescribed Treatment for Asthma: Evidence from Pharmacy Benefits Data

1 reference

12 December 2020

Clinical trial design, nasal allergen challenge models, and considerations of relevance to pediatrics, nasal polyposis, and different classes of medication

1 reference

12 December 2020

Clinical evidence for antileukotriene therapy in the management of allergic rhinitis

1 reference

12 December 2020

Regression to the mean: treatment effect without the intervention.

1 reference

12 December 2020

Rhinitis as an independent risk factor for adult-onset asthma.

1 reference

12 December 2020

Allergy and allergic diseases. First of two parts

1 reference

12 December 2020

Efficacy and safety of montelukast in adults with asthma and allergic rhinitis.

1 reference

12 December 2020

Montelukast: a review of its therapeutic potential in persistent asthma

1 reference

12 December 2020

One airway, one disease

1 reference

12 December 2020

Efficacy of montelukast during the allergy season in patients with chronic asthma and seasonal aeroallergen sensitivity

1 reference

12 December 2020

Montelukast for treating fall allergic rhinitis: effect of pollen exposure in 3 studies

1 reference

12 December 2020

The role of leukotrienes in allergic rhinitis

1 reference

12 December 2020

Comparative degree and type of sensitization to common indoor and outdoor allergens in subjects with allergic rhinitis and/or asthma.

1 reference

12 December 2020

Linear growth in prepubertal asthmatic children treated with montelukast, beclomethasone, or placebo: a 56-week randomized double-blind study

1 reference

12 December 2020

Comparison of fluticasone propionate aqueous nasal spray and oral montelukast for the treatment of seasonal allergic rhinitis symptoms

1 reference

12 December 2020

Detection of growth suppression in children during treatment with intranasal beclomethasone dipropionate

1 reference

12 December 2020

The role of antileukotrienes in the treatment of asthma

1 reference

12 December 2020

Effect of montelukast on lung function in asthma patients with allergic rhinitis: analysis from the COMPACT trial

1 reference

12 December 2020

Allergic rhinitis and its impact on asthma

1 reference

12 December 2020

Allergic rhinobronchitis: the asthma-allergic rhinitis link

1 reference

12 December 2020

A review of montelukast in the treatment of asthma and allergic rhinitis

1 reference

12 December 2020

Neurobiological mechanisms of the placebo effect.

1 reference

12 December 2020

The leukotriene C(4) transporter MRP1 regulates CCL19 (MIP-3beta, ELC)-dependent mobilization of dendritic cells to lymph nodes

1 reference

12 December 2020

Montelukast-associated Churg-Strauss syndrome

1 reference

12 December 2020

Effects of topical corticosteroid and combined mediator blockade on domiciliary and laboratory measurements of nasal function in seasonal allergic rhinitis

1 reference

12 December 2020

Effects of monotherapy with intra-nasal corticosteroid or combined oral histamine and leukotriene receptor antagonists in seasonal allergic rhinitis

1 reference

12 December 2020

Asthma therapies and Churg-Strauss syndrome

1 reference

12 December 2020

Seasonal versus perennial allergic rhinitis: drug and medical resource use patterns

1 reference

12 December 2020

Leukotriene receptor antagonists for allergic rhinitis: a systematic review and meta-analysis.

1 reference

12 December 2020

Publication and related biases

1 reference

12 December 2020

Complications of allergic rhinitis.

1 reference

12 December 2020

Effect of a concomitant diagnosis of allergic rhinitis on asthma-related health care use by adults.

1 reference

12 December 2020

Intranasal steroid reduces exhaled bronchial cysteinyl leukotrienes in allergic patients

1 reference

12 December 2020

Safety and tolerability of treatments for allergic rhinitis in children

1 reference

12 December 2020

Treating allergic rhinitis in patients with comorbid asthma: the risk of asthma-related hospitalizations and emergency department visits

1 reference

12 December 2020

Allergic rhinitis/asthma interrelationships

1 reference

12 December 2020

Perennial rhinitis: An independent risk factor for asthma in nonatopic subjects☆☆☆★Results from the European Community Respiratory Health Survey

1 reference

12 December 2020

Eosinophils are a feature of upper and lower airway pathology in non-atopic asthma, irrespective of the presence of rhinitis

1 reference

12 December 2020

Allergic rhinitis: systemic inflammation and implications for management

1 reference

12 December 2020

A common pathway: asthma and allergic rhinitis

1 reference

12 December 2020

Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis

1 reference

12 December 2020

Comparison of montelukast and pseudoephedrine in the treatment of allergic rhinitis

1 reference

12 December 2020

Onset of efficacy of montelukast in seasonal allergic rhinitis.

1 reference

12 December 2020

Leukotriene C4 release in upper respiratory mucosa during natural exposure to ragweed in ragweed-sensitive children

1 reference

12 December 2020

The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis

1 reference

12 December 2020

Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall

1 reference

12 December 2020

Montelukast effectively treats the nighttime impact of seasonal allergic rhinitis

1 reference

12 December 2020

The unified immune system: respiratory tract-nasobronchial interaction mechanisms in allergic airway disease

1 reference

12 December 2020

Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial

1 reference

12 December 2020

Effect of montelukast on symptoms and exhaled nitric oxide levels in 7- to 14-year-old children with seasonal allergic rhinitis

1 reference

12 December 2020

Randomized, double-blind, placebo-controlled study of montelukast for treating perennial allergic rhinitis

1 reference

12 December 2020

Prevalence of serious eosinophilia and incidence of Churg-Strauss syndrome in a cohort of asthma patients

1 reference

12 December 2020

Montelukast improves symptoms of seasonal allergic rhinitis over a 4‐week treatment period

1 reference

12 December 2020

Leukotriene E4 and granulocytic infiltration into asthmatic airways

1 reference

12 December 2020

Unique mechanistic features of allergic rhinitis

1 reference

12 December 2020

The relationship of asthma therapy and Churg-Strauss syndrome: NIH workshop summary report

1 reference

12 December 2020

Toll-like receptor agonists differentially regulate cysteinyl-leukotriene receptor 1 expression and function in human dendritic cells.

1 reference

12 December 2020

Segmental bronchoprovocation in allergic rhinitis patients affects mast cell and basophil numbers in nasal and bronchial mucosa

1 reference

12 December 2020

Randomized placebo-controlled trial comparing montelukast and cetirizine for treating perennial allergic rhinitis in children aged 2-6 yr.

1 reference

12 December 2020

Fluticasone nasal spray and the combination of loratadine and montelukast in seasonal allergic rhinitis

1 reference

12 December 2020

Fluticasone propionate nasal spray is superior to montelukast for allergic rhinitis while neither affects overall asthma control

1 reference

12 December 2020

Allergic rhinitis: a potential cause of increased asthma medication use, costs, and morbidity

1 reference

12 December 2020

Clinical safety and tolerability of montelukast, a leukotriene receptor antagonist, in controlled clinical trials in patients aged > or = 6 years

1 reference

12 December 2020

Pulmonary infiltrates, eosinophilia, and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukast

1 reference

12 December 2020

The impact of allergic rhinitis on bronchial asthma

1 reference

12 December 2020

Interpreting atmospheric pollen counts for use in clinical allergy: allergic symptomology

1 reference

12 December 2020

Patient preferences and sensory comparisons of three intranasal corticosteroids for the treatment of allergic rhinitis

1 reference

12 December 2020

1 reference

12 December 2020

Greater risk of incident asthma cases in adults with allergic rhinitis and effect of allergen immunotherapy: a retrospective cohort study

1 reference

12 December 2020

Increased risk of asthma attacks and emergency visits among asthma patients with allergic rhinitis: a subgroup analysis of the investigation of montelukast as a partner agent for complementary therapy [corrected].

1 reference

12 December 2020

A comparison of once daily fexofenadine versus the combination of montelukast plus loratadine on domiciliary nasal peak flow and symptoms in seasonal allergic rhinitis

1 reference

12 December 2020

Montelukast with desloratadine or levocetirizine for the treatment of persistent allergic rhinitis

1 reference

12 December 2020

Pharmacokinetics and safety of montelukast in children aged 3 to 6 months

1 reference

12 December 2020

Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years

1 reference

12 December 2020

Long-term risk factors for developing asthma and allergic rhinitis: a 23-year follow-up study of college students.

1 reference

12 December 2020

Changes in bronchial responsiveness following nasal provocation with allergen

1 reference

12 December 2020

Leukotrienes are potent constrictors of human bronchi

1 reference

12 December 2020

Asthma rescue and allergy medication use among asthmatic children with prior allergy prescriptions who initiated asthma controller therapy

1 reference

12 December 2020

Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring

1 reference

12 December 2020

Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis

1 reference

12 December 2020

Peptide Leukotriene Release after Antigen Challenge in Patients Sensitive to Ragweed

1 reference

12 December 2020

10.2165/00003495-200767060-00005

Identifiers

DOI

1 reference

PubMed ID

17428106

Dimensions Publication ID

16 August 2017

0 references

1 reference

PubMed ID

17428106